NFA
CBIO

Nationwide Fund Advisors’s Crescent Biopharma CBIO Stock Holding History

Nationwide Fund Advisors’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-149
Closed -$208K – 835
2017
Q3 		$208K Hold
149
– – ﹤0.01% 2623
2017
Q2 		$166K Sell
149
-70
-32% -$57.8K ﹤0.01% 2705
2017
Q1 		$119K Hold
219
– – ﹤0.01% 2785
2016
Q4 		$134K Hold
219
– – ﹤0.01% 2773
2016
Q3 		$157K Hold
219
– – ﹤0.01% 2737
2016
Q2 		$159K Buy
219
+61
+39% +$42K ﹤0.01% 2716
2016
Q1 		$94K Hold
158
– – ﹤0.01% 2844
2015
Q4 		$90K Hold
158
– – ﹤0.01% 2881
2015
Q3 		$88K Hold
158
– – ﹤0.01% 2932
2015
Q2 		$125K Sell
158
-62
-28% -$51.3K ﹤0.01% 2941
2015
Q1 		$183K Hold
220
– – ﹤0.01% 2735
2014
Q4 		$158K Hold
220
– – ﹤0.01% 2749
2014
Q3 		$152K Hold
220
– – ﹤0.01% 2823
2014
Q2 		$185K Buy
220
+33
+18% +$32.9K ﹤0.01% 2789
2014
Q1 		$305K Buy
+187
New +$226K ﹤0.01% 2300

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return